Squarepoint Ops LLC boosted its stake in shares of MAXIMUS, Inc. (NYSE:MMS) by 6.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 82,805 shares of the health services provider’s stock after purchasing an additional 4,976 shares during the period. Squarepoint Ops LLC owned about 0.13% of MAXIMUS worth $6,398,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the business. Advisory Services Network LLC lifted its holdings in shares of MAXIMUS by 499.0% during the 2nd quarter. Advisory Services Network LLC now owns 593 shares of the health services provider’s stock valued at $43,000 after buying an additional 494 shares during the last quarter. Quantamental Technologies LLC acquired a new position in MAXIMUS in the second quarter worth approximately $71,000. Signaturefd LLC raised its position in MAXIMUS by 19.6% during the second quarter. Signaturefd LLC now owns 1,145 shares of the health services provider’s stock valued at $83,000 after acquiring an additional 188 shares in the last quarter. Coastal Investment Advisors Inc. bought a new position in MAXIMUS during the third quarter valued at approximately $103,000. Finally, Tower Research Capital LLC TRC lifted its stake in MAXIMUS by 70.8% in the second quarter. Tower Research Capital LLC TRC now owns 1,500 shares of the health services provider’s stock valued at $109,000 after acquiring an additional 622 shares during the last quarter. Hedge funds and other institutional investors own 94.95% of the company’s stock.

Several brokerages have recently commented on MMS. ValuEngine upgraded shares of MAXIMUS from a “sell” rating to a “hold” rating in a research note on Friday, October 25th. Canaccord Genuity raised their price target on shares of MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a report on Tuesday, August 13th. Finally, Wells Fargo & Co reaffirmed a “market perform” rating and issued a $83.00 price objective on shares of MAXIMUS in a research note on Friday, August 9th.

MMS opened at $74.15 on Tuesday. The company has a market cap of $4.78 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 1.84 and a beta of 0.79. The stock has a 50-day moving average of $75.74 and a 200-day moving average of $75.20. MAXIMUS, Inc. has a 52-week low of $62.00 and a 52-week high of $82.02.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Tuesday, November 19th. The health services provider reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.01). MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. The company had revenue of $754.97 million for the quarter, compared to analyst estimates of $756.40 million. During the same period in the prior year, the company posted $0.71 EPS. The business’s revenue was up 35.2% on a year-over-year basis. On average, research analysts predict that MAXIMUS, Inc. will post 4.05 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend was Thursday, November 14th. This is an increase from MAXIMUS’s previous quarterly dividend of $0.25. MAXIMUS’s dividend payout ratio (DPR) is 30.11%.

In related news, General Counsel David Francis sold 6,496 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $77.43, for a total transaction of $502,985.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $78.04, for a total transaction of $936,480.00. Following the completion of the transaction, the insider now owns 337,874 shares in the company, valued at $26,367,686.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,496 shares of company stock worth $4,398,575. Corporate insiders own 2.20% of the company’s stock.


MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: Depreciation

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.